Figure (A): While maintaining consistency with the original process, CelluPro customized media significantly increased the viable cell density (VCD) and peak VCD of the client‘s original process, and maintained good cell viability (Via) in the late culture stages.

Figure (B): Through CelluPro’s customized optimization of the media for this cell line, the client’s expression level significantly increased to 8.69 g/L.

Figure (A): Through optimization of the media formulation and culture process, the charge distribution characteristics of the antibody were significantly improved.

Figure (B): In response to the client’s need for glycosylation modification, media formulation optimization achieved a high similarity between the antibody glycan profile and that of the originator drug.